The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Jul. 10, 2008
Monique Arpin, Paris, FR;
Yasmin Ataman-onal, Reyrieux, FR;
Corinne Beaulieu, Rillieux la Pape, FR;
Sandrine Busseret, Lyons, FR;
Jean-philippe Charrier, Tassin la Demi-Lune, FR;
Genevieve Choquet-kastylevsky, Francheville, FR;
Dominique Rolland, Saint Genis les Ollieres, FR;
Monique Arpin, Paris, FR;
Yasmin Ataman-Onal, Reyrieux, FR;
Corinne Beaulieu, Rillieux la Pape, FR;
Sandrine Busseret, Lyons, FR;
Jean-Philippe Charrier, Tassin la Demi-Lune, FR;
Genevieve Choquet-Kastylevsky, Francheville, FR;
Dominique Rolland, Saint Genis les Ollieres, FR;
Biomerieux, Marcy l'Etoile, FR;
Centre National de la Recherche Scientifique, Paris, FR;
Institut Curie, Paris, FR;
Abstract
A method for the in vitro diagnosis of colorectal cancer by determining the presence of the Ezrin tumor marker in a biological sample taken from a patient suspected of having colorectal cancer using at least one anti-Ezrin monoclonal antibody directed against an Ezrin epitope chosen from the epitopes of sequence SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, SEQ ID No. 4+SEQ ID No. 5, SEQ ID No. 6+SEQ ID No. 7 and SEQ ID No. 8. Said method can be used for early diagnosis, screening, therapeutic follow-up and prognosis, and also for relapse diagnosis in relation to colorectal cancer.